AllianceBernstein’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$878K Buy
226,778
+20,670
+10% +$89.3K ﹤0.01% 2440
2026
Q1
$862K Buy
206,108
+58
+0% +$238 ﹤0.01% 2396
2025
Q4
$861K Buy
206,050
+52,530
+34% +$203K ﹤0.01% 2410
2025
Q3
$505K Sell
153,520
-89,420
-37% -$252K ﹤0.01% 2668
2025
Q2
$345K Buy
242,940
+16,280
+7% +$23.1K ﹤0.01% 2848
2025
Q1
$338K Hold
226,660
﹤0.01% 2720
2024
Q4
$254K Hold
226,660
﹤0.01% 2950
2024
Q3
$215K Hold
226,660
﹤0.01% 3020
2024
Q2
$358K Buy
226,660
+41,890
+23% +$60.8K ﹤0.01% 2844
2024
Q1
$268K Hold
184,770
﹤0.01% 2843
2023
Q4
$248K Sell
184,770
-11,980
-6% -$14.1K ﹤0.01% 2917
2023
Q3
$279K Sell
196,750
-11,850
-6% -$16.8K ﹤0.01% 2831
2023
Q2
$240K Buy
208,600
+45,100
+28% +$53.2K ﹤0.01% 2935
2023
Q1
$173K Sell
163,500
-2,000
-1% -$2.88K ﹤0.01% 2946
2022
Q4
$252K Buy
165,500
+6,000
+4% +$10.3K ﹤0.01% 2926
2022
Q3
$338K Buy
159,500
+25,500
+19% +$53.8K ﹤0.01% 2815
2022
Q2
$180K Buy
134,000
+14,200
+12% +$21.1K ﹤0.01% 3045
2022
Q1
$253K Buy
119,800
+300
+0.3% +$730 ﹤0.01% 2930
2021
Q4
$443K Hold
119,500
﹤0.01% 2795
2021
Q3
$596K Hold
119,500
﹤0.01% 2694
2021
Q2
$779K Buy
119,500
+39,200
+49% +$274K ﹤0.01% 2637
2021
Q1
$553K Sell
80,300
-13,300
-14% -$112K ﹤0.01% 2625
2020
Q4
$955K Sell
93,600
-23,400
-20% -$152K ﹤0.01% 2311
2020
Q3
$410K Sell
117,000
-21,700
-16% -$103K ﹤0.01% 2634
2020
Q2
$692K Buy
138,700
+27,100
+24% +$92.2K ﹤0.01% 2409
2020
Q1
$379K Sell
111,600
-33,600
-23% -$145K ﹤0.01% 2492
2019
Q4
$796K Hold
145,200
﹤0.01% 2365
2019
Q3
$831K Hold
145,200
﹤0.01% 2325
2019
Q2
$1.11M Buy
145,200
+8,400
+6% +$45.2K ﹤0.01% 2267
2019
Q1
$720K Buy
136,800
+11,750
+9% +$81.5K ﹤0.01% 2398
2018
Q4
$818K Sell
125,050
-2,000
-2% -$22.4K ﹤0.01% 2283
2018
Q3
$2.19M Buy
127,050
+12,550
+11% +$187K ﹤0.01% 1883
2018
Q2
$1.6M Buy
114,500
+61,671
+117% +$1.04M ﹤0.01% 2075
2018
Q1
$810K Buy
52,829
+17,469
+49% +$250K ﹤0.01% 2350
2017
Q4
$407K Buy
35,360
+1,800
+5% +$26.8K ﹤0.01% 2596
2017
Q3
$638K Buy
33,560
+950
+3% +$19.6K ﹤0.01% 2490
2017
Q2
$786K Buy
32,610
+200
+0.6% +$4.39K ﹤0.01% 2417
2017
Q1
$642K Sell
32,410
-393
-1% -$8.77K ﹤0.01% 2447
2016
Q4
$790K Sell
32,803
-479
-1% -$13.3K ﹤0.01% 2377
2016
Q3
$924K Sell
33,282
-18,061
-35% -$478K ﹤0.01% 2260
2016
Q2
$1.25M Buy
51,343
+20,079
+64% +$570K ﹤0.01% 2085
2016
Q1
$1.05M Buy
31,264
+641
+2% +$20.2K ﹤0.01% 2063
2015
Q4
$915K Sell
30,623
-606
-2% -$20.4K ﹤0.01% 2176
2015
Q3
$984K Buy
31,229
+1,161
+4% +$56.6K ﹤0.01% 2183
2015
Q2
$1.45M Sell
30,068
-32,712
-52% -$1.38M ﹤0.01% 2056
2015
Q1
$2.72M Sell
62,780
-4,499
-7% -$162K ﹤0.01% 1500
2014
Q4
$1.77M Hold
67,279
﹤0.01% 1838
2014
Q3
$1.2M Sell
67,279
-4,813
-7% -$98.3K ﹤0.01% 2081
2014
Q2
$1.73M Buy
72,092
+40,234
+126% +$816K ﹤0.01% 1888
2014
Q1
$800K Buy
31,858
+8,371
+36% +$232K ﹤0.01% 2263
2013
Q4
$534K Buy
23,487
+23,438
+47,833% +$474K ﹤0.01% 2415
2013
Q3
$1K Buy
+49
New +$1.13K ﹤0.01% 3378

Other funds holding PGEN

AllianceBernstein's PGEN Position: Q2 2026 in Review

AllianceBernstein increased its Precigen (PGEN) stake by 10% in Q2 2026, buying an estimated $89.3K and bringing the position to 226,778 shares worth $878K. The position accounts for ﹤0.01% of the portfolio, ranked #2440.

AllianceBernstein first reported a position in PGEN in Q3 2013 and has held it in 52 quarters since. The position peaked at $2.72M in Q1 2015. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • AllianceBernstein held 226,778 shares of Precigen worth $878K as of Q2 2026.
  • AllianceBernstein bought 20,670 Precigen shares in Q2 2026, an estimated $89.3K.
  • Precigen made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #2440 holding.
  • AllianceBernstein first reported a position in Precigen in Q3 2013 and has held it in 52 quarters since.
  • AllianceBernstein's Precigen position peaked at $2.72M in Q1 2015.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.